Neuronetics STIM Clinical Services — Selling General And Administrative Expense

Other segment segments

Similar metrics at other companies

FTREClinical Services Segment — Selling, general and administrative expenses, exclusive of depreciation and amortization

$89.1M-15.0%

SLQTHealthcare Services — Selling, General and Administrative Expense

$15.31M+10.6%

RESSupport Services — Selling General And Administrative Expense

$4.54M+3.5%

FSISelling General And Administrative Expense

$762.36K+0.8%

VRRMCommercial Services — Selling General And Administrative Expense Net Of Non Operating Performance Measures

$17.12M-12.6%

WORConsumer Products — Selling General And Administrative Expense

$28.18M-0.8%

Questions, answered.

What is Neuronetics's clinical services — selling general and administrative expense?

Neuronetics (STIM) reported clinical services — selling general and administrative expense of $7.88M in Q1 2026.

How has Neuronetics's clinical services — selling general and administrative expense changed year-over-year?

Neuronetics's clinical services — selling general and administrative expense decreased by 0.6% year-over-year, from $7.93M to $7.88M.

What does clinical services — selling general and administrative expense mean?

This metric represents the operating expenses incurred to support, market, and manage the clinical services segment, excluding direct production costs. It provides insight into the overhead burden and commercial infrastructure investment required to sustain the service business.